37.15
price up icon0.60%   0.22
after-market Handel nachbörslich: 37.13 -0.02 -0.05%
loading
Schlusskurs vom Vortag:
$36.93
Offen:
$36.93
24-Stunden-Volumen:
324.50K
Relative Volume:
0.85
Marktkapitalisierung:
$1.87B
Einnahmen:
$345.60M
Nettoeinkommen (Verlust:
$-79.01M
KGV:
-23.15
EPS:
-1.6045
Netto-Cashflow:
$-18.62M
1W Leistung:
+5.69%
1M Leistung:
+18.54%
6M Leistung:
+19.76%
1J Leistung:
-5.42%
1-Tages-Spanne:
Value
$36.62
$37.62
1-Wochen-Bereich:
Value
$35.17
$37.62
52-Wochen-Spanne:
Value
$23.15
$40.88

Immunocore Holdings Plc Adr Stock (IMCR) Company Profile

Name
Firmenname
Immunocore Holdings Plc Adr
Name
Telefon
01235 5430281
Name
Adresse
90 PARK DRIVE, OXFORDSHIRE
Name
Mitarbeiter
493
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
IMCR's Discussions on Twitter

Vergleichen Sie IMCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMCR
Immunocore Holdings Plc Adr
37.15 1.77B 345.60M -79.01M -18.62M -1.6045
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-27 Eingeleitet Deutsche Bank Buy
2024-12-13 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-11-11 Herabstufung Mizuho Outperform → Neutral
2024-10-24 Eingeleitet UBS Sell
2024-10-07 Herabstufung Guggenheim Buy → Neutral
2024-04-29 Eingeleitet Leerink Partners Outperform
2023-11-20 Fortgesetzt JP Morgan Overweight
2023-11-02 Eingeleitet Cantor Fitzgerald Overweight
2023-10-31 Eingeleitet Robert W. Baird Outperform
2023-09-13 Hochstufung JP Morgan Neutral → Overweight
2023-09-13 Eingeleitet Needham Buy
2023-08-16 Eingeleitet CapitalOne Overweight
2023-07-17 Eingeleitet Canaccord Genuity Hold
2023-03-31 Eingeleitet Mizuho Buy
2023-03-30 Eingeleitet Guggenheim Buy
2023-03-24 Eingeleitet Bryan Garnier Buy
2022-12-16 Hochstufung Goldman Neutral → Buy
2022-11-30 Eingeleitet Barclays Overweight
2022-09-09 Eingeleitet Morgan Stanley Overweight
2022-09-08 Eingeleitet Ladenburg Thalmann Buy
2022-08-08 Eingeleitet Cowen Outperform
2022-08-02 Eingeleitet BTIG Research Buy
2022-02-08 Eingeleitet H.C. Wainwright Buy
2021-10-20 Eingeleitet Oppenheimer Outperform
2021-03-02 Eingeleitet Goldman Neutral
2021-03-02 Eingeleitet JP Morgan Overweight
2021-03-02 Eingeleitet Jefferies Buy
Alle ansehen

Immunocore Holdings Plc Adr Aktie (IMCR) Neueste Nachrichten

pulisher
Jul 13, 2025

Principal Financial Group Inc. Reduces Stock Holdings in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) - Defense World

Jul 13, 2025
pulisher
Jul 08, 2025

MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - sharewise.com

Jul 08, 2025
pulisher
Jul 08, 2025

COGT Stock Soars on Phase III Systemic Mastocytosis Study Success - sharewise.com

Jul 08, 2025
pulisher
Jul 02, 2025

Apellis Stock Rises On $300M Royalty Deal With Sobi For Aspaveli - Barchart.com

Jul 02, 2025
pulisher
Jul 01, 2025

Oppenheimer Asset Management Inc. Makes New Investment in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) - Defense World

Jul 01, 2025
pulisher
Jun 24, 2025

Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - MSN

Jun 24, 2025
pulisher
Jun 14, 2025

Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges By Investing.com - Investing.com South Africa

Jun 14, 2025
pulisher
Jun 14, 2025

Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges - Investing.com India

Jun 14, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for Immunocore FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

GAMMA Investing LLC Boosts Stock Position in Immunocore Holdings plc (NASDAQ:IMCR) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Immunocore at Jefferies Global Healthcare Conference: Strong Growth and Promising Trials - Investing.com India

Jun 05, 2025
pulisher
Jun 03, 2025

H.C. Wainwright reiterates buy rating on Immunocore stock amid ASCO update - Investing.com

Jun 03, 2025
pulisher
Jun 02, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet - sharewise

Jun 02, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy - Investing.com

May 27, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy By Investing.com - Investing.com India

May 27, 2025
pulisher
May 26, 2025

Immunocore’s SWOT analysis: biotech firm’s stock faces challenges amid growth - Investing.com India

May 26, 2025
pulisher
May 24, 2025

Is it a Good Idea to Invest in Immunocore Stock Right Now? - MSN

May 24, 2025
pulisher
May 09, 2025

Balance Sheet Dive: Hippo Holdings Inc (HIPO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX

May 09, 2025
pulisher
May 08, 2025

New Strong Buy Stocks for May 8th - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Immunocore Holdings earnings beat by $0.49, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

ESPR's Q1 Earnings Miss Estimates, Revenues Beat, Stock Down - Barchart.com

May 06, 2025
pulisher
May 06, 2025

AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - The Globe and Mail

May 06, 2025
pulisher
May 02, 2025

Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates - Barchart.com

May 02, 2025
pulisher
Apr 30, 2025

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet - Yahoo Finance

Apr 30, 2025
pulisher
Apr 07, 2025

Mizuho cuts Immunocore stock price target to $33 from $38 - Investing.com

Apr 07, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Mar 28, 2025

Do investors need to be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News

Mar 28, 2025
pulisher
Mar 22, 2025

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last? - MSN

Mar 22, 2025
pulisher
Mar 19, 2025

Immunocore holdings sees $23.99 million in stock purchases by Baker Bros - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 17, 2025

Immunocore amends senior notes indenture, files prospectus - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Immunocore amends senior notes indenture, files prospectus By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 12, 2025

H.C. Wainwright maintains $100 target on Immunocore stock - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Immunocore’s SWOT analysis: biotech firm’s stock outlook amid HIV and cancer drug progress - Investing.com

Mar 12, 2025
pulisher
Mar 11, 2025

BTIG maintains Immunocore stock Buy rating, $91 target - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Immunocore stock hits 52-week low at $27.59 amid market challenges - Investing.com

Mar 11, 2025
pulisher
Mar 10, 2025

Immunocore reports promising HIV trial results By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Immunocore reports promising HIV trial results - Investing.com India

Mar 10, 2025

Finanzdaten der Immunocore Holdings Plc Adr-Aktie (IMCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):